Barely Significant
← all excerpts

Fabrication of New Hybrid Scaffolds for <i>in vivo</i> Perivascular Application to Treat Limb Ischemia.

Front Cardiovasc Med · 2020 · PMC7711071 · PMID 33330660

1
hedged sentence
closest p
boldest claim

The sentences

The APC-bioengineered scaffolds showed a BAX/BCL2 ratio superior to 2D control counterparts, but the difference did not reach statistical significance (PCL: 2.48 ± 0.58-fold change vs. 2D; PLGA: 1.47 ± 0.19-fold change vs. 2D).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.